Key result
Adjunctive IV Corvitin linked to improved myocardial function and fewer early complications in emergency CABG.
Why the study?
The effects of intravenous Corvitin added to standard treatment for myocardial protection in ACS patients undergoing emergency CABG were investigated to reduce ischemic/reperfusion damage and postoperative complications.
Does intravenous Corvitin improve myocardial function and reduce postoperative complications in patients with ACS undergoing emergency CABG?
Does intravenous Corvitin improve myocardial function and reduce postoperative complications in patients with ACS undergoing emergency CABG?
Answers are grounded in this paper and cite their sources.
Perioperative administration of intravenous Corvitin may improve myocardial function and reduce early postoperative complications in ACS patients undergoing emergency CABG.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gelis et al. (2012) studied Acute coronary syndromes (ACS) undergoing emergency CABG (n=76). Intravenous Corvitin vs. Standard treatment was evaluated on Systolic and diastolic myocardial function and early postoperative cardiovascular complications. Intravenous Corvitin added to standard treatment improved systolic and diastolic myocardial function and reduced the risk of early postoperative cardiovascular complications in patients with ACS undergoing emergency CABG.
Synapse has enriched 10 related papers. Consider them for comparative context: